1. Amiel SA, Stewart JF, Earl HM, Knight RK, Rubens RD (1985) Adriamycin and mitomycin C as initial chemotherapy for advanced breast cancer. Eur J Cancer Clin Oncol 21: 1475
2. Arena E, D'Alessandro N, dusonchet L, Gebbia N, Gerbasi F, Palazzoadriano M, Raineri A, Rausa L, Tubaro E (1971) Analysis of the pharmacokinetic characteristics, pharmacological and chemotherapeutic activity of 14-hydroxydaunomycin (Adriamycin), a new drug endowed with an antitumour activity. Arzneim-Forsch 21: 1258?1263
3. Bachur NR, Hildebrand RC, Jaenke RS (1974) Adriamycin and daunorubicin disposition in the rabbit. J Pharmacol Exp Ther 191: 331?340
4. Beck WT, Mueller RJ, Tanzer LR (1979) Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukaemic lymphoblasts. Cancer Res 39: 2070?2076
5. Bonadonna G, Monfardini S, De Lena M (1970) Phase I and preliminary phase II evaluation of Adriamycin. Cancer Res 30: 2572?2582